These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38582821)

  • 21. Computational Simulation Study of Potential Inhibition of c-Met Kinase Receptor by Phenoxy pyridine Derivatives: Based on QSAR, Molecular Docking, Molecular Dynamics.
    Guo LY; Yang YL; Tong JB; Chang ZL; Gao P; Liu Y; Zhang YK; Xing XY
    Chem Biodivers; 2024 Oct; 21(10):e202400782. PubMed ID: 38923279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular docking and MD simulation studies of 4-thiazol-N-(pyridin-2-yl)pyrimidin-2-amine derivatives as novel inhibitors targeted to CDK2/4/6.
    Liang JD; Zhang YE; Qin F; Chen WN; Jiang WM; Fang Z; Liang XL; Zhang Q; Li J
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):302. PubMed ID: 38856753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-combined 3D-QSAR, docking molecular and ADMET prediction of 5-azaindazole derivatives as LRRK2 tyrosine kinase inhibitors.
    Khamouli S; Belaidi S; Ouassaf M; Lanez T; Belaaouad S; Chtita S
    J Biomol Struct Dyn; 2022 Feb; 40(3):1285-1298. PubMed ID: 32964807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase.
    Aouidate A; Ghaleb A; Ghamali M; Ousaa A; Choukrad M; Sbai A; Bouachrine M; Lakhlifi T
    Comput Biol Chem; 2018 Jun; 74():201-211. PubMed ID: 29635214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined machine learning models, docking analysis, ADMET studies and molecular dynamics simulations for the design of novel FAK inhibitors against glioblastoma.
    Zhao Y; He X; Wan Q
    BMC Chem; 2024 Oct; 18(1):203. PubMed ID: 39425154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive models for designing potent tyrosine kinase inhibitors in chronic myeloid leukemia for understanding its molecular mechanism of resistance by molecular docking and dynamics simulations.
    Melge AR; Kumar LG; K P; Nair SV; K M; C GM
    J Biomol Struct Dyn; 2019 Nov; 37(18):4747-4766. PubMed ID: 30580670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of novel DABO derivatives as HIV-1 RT inhibitors using molecular docking, molecular dynamics simulations and ADMET properties.
    Zhang Y; Chen L; Wang Z; Zhu Y; Jiang H; Xu J; Xiong F
    J Biomol Struct Dyn; 2024 May; 42(8):4196-4213. PubMed ID: 37272892
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Akabli T; Toufik H; Lamchouri F
    J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
    He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
    Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of QSAR Global Models and Molecular Docking for Developing New Inhibitors of c-src Tyrosine Kinase.
    Ancuceanu R; Tamba B; Stoicescu CS; Dinu M
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modeling studies on series of Btk inhibitors using docking, structure-based 3D-QSAR and molecular dynamics simulation: a combined approach.
    Balasubramanian PK; Balupuri A; Cho SJ
    Arch Pharm Res; 2016 Mar; 39(3):328-39. PubMed ID: 26699616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Descriptor-free QSAR: effectiveness in screening for putative inhibitors of FGFR1.
    Joel IY; Sulaimon LA; Idris MO; Adigun TO; Adisa RA; Ademoye TA; Ogunleye MO; Olaniyi TO
    J Biomol Struct Dyn; 2023 Mar; 41(5):2016-2032. PubMed ID: 35073829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.
    Oluić J; Nikolic K; Vucicevic J; Gagic Z; Filipic S; Agbaba D
    Comb Chem High Throughput Screen; 2017 Aug; 20(4):292-303. PubMed ID: 28460621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2D-QSAR study, molecular docking, and molecular dynamics simulation studies of interaction mechanism between inhibitors and transforming growth factor-beta receptor I (ALK5).
    Jiang MN; Zhou XP; Sun DR; Gao H; Zheng QC; Zhang HX; Liang D
    J Biomol Struct Dyn; 2018 Nov; 36(14):3705-3717. PubMed ID: 29064324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combined
    Guendouzi A; Belkhiri L; Guendouzi A; Derouiche TMT; Djekoun A
    J Biomol Struct Dyn; 2024; 42(1):119-133. PubMed ID: 36995063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived from Imidazo[4,5-
    Tian YY; Tong JB; Liu Y; Tian Y
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles.
    Yu CX; Tan JW; Rullah K; Imran S; Tham CL
    J Biomol Struct Dyn; 2023; 41(22):12978-12996. PubMed ID: 36709457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSAR study of tetrahydropteridin derivatives as polo-like kinase 1(PLK1) Inhibitors with molecular docking and dynamics study.
    Garima ; Sharma S; Sindhu J; Kumar P
    SAR QSAR Environ Res; 2023 Feb; 34(2):91-116. PubMed ID: 36744430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unveiling G-protein coupled receptor kinase-5 inhibitors for chronic degenerative diseases: Multilayered prioritization employing explainable machine learning-driven multi-class QSAR, ligand-based pharmacophore and free energy-inspired molecular simulation.
    Bhattacharjee A; Kar S; Ojha PK
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):131784. PubMed ID: 38697440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.